To reveal the role of UBE2C in regulating TMZ resistance in gliomas, we first assessed its expression levels in the brain tissues of TMZ-resistant and TMZ-sensitive glioma patients, as well as in normal brain tissues. This evidence concerns the gene UBE2C and central nervous system cancer.